medigraphic.com
SPANISH

Dermatología Cosmética, Médica y Quirúrgica

Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2010, Number 3

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2010; 8 (3)

Pyoderma gangrenosum: Incidence and associations in Dr. Manuel Gea González General Hospital (1993 to 2009)

De Anda JMC, Karam OM, Gómez VR, Reyes MG, Sáenz CC, Plascencia GA, Vega MME
Full text How to cite this article

Language: Spanish
References: 10
Page: 184-186
PDF size: 210.62 Kb.


Key words:

pyoderma gangrenosum, neutrofilic dermatosis, ulcers, CUCI.

ABSTRACT

Background: Pyoderma gangrenosum is a neutrofilic ulcerative dermatosis associated with systemic diseases in 50 to 70%. The most common association found is with inflammatory bowel disease. There are four common clinical variants: blistering, pustular, granulomatous and vegetans. The histologic findings are nonspecific neutrofilic infiltrates with leucocitoclasia and necrosis. First line treatment consists in corticosteroids, and cyclosporine, associated with immunonodulators in resistant cases.
Patients and methods: In a retrospective study from January 1993 to December 2009 we included all patients with clinical and histologic diagnosis of pyoderma gangrenosum.
Results: Out of all 18 patients in 17 years with diagnosis of pyoderma gangrenosum, 9 had no found association with systemic diseases (55.5%); 4, associations with chronic ulcerative colitis (22.2%); 2 with rheumatoid arthritis (11.1%); 2 with leukemia (11.1%) and 1 association with pregnancy (5.55%).
Conclusions: Pyoderma gangrenosum is a rare dermatologic disease. 44.5 % of our patients had some association with a systemic disease and in some cases precedes the diagnosis for years.


REFERENCES

  1. Bolognia JL, Jorizzo JL, Rapinni RP y cols. Neutrophilic dermatoses: Pyoderma gangrenosum. En Dermatology, 2a ed, cap 27, 2008, 383-386.

  2. Jeffrey P, Callen J, Jackson M. “Pyoderma gangrenosum: An update”. Rheum Dis Clin N Am 2007; 33 787-802.

  3. Velázquez N, Festa C, Sakay N. “Pioderma gangrenoso: Revisión de 29 casos clínicos”. Med Cután Iber Lat Am 2000; 28 (4): 162-166.

  4. Poritz L, Lebo M y cols. “Management of peristomal pyoderma gangrenosum”. J Am Coll Surg 2008; 206: 311-315.

  5. Mc Aleer M, Powell F, Devaney D y cols. “Infantile pyoderma gangrenosum”. J Am Acad Dermatol 2008; 58: S23-S28.

  6. Freiman A, Brassard A. “Pyoderma gangrenosum associated with isotretinoin therapy”. J Am Acad Dermatol 2006; 55 (supl. 5): S107-S108.

  7. Lopez de Maturana D, Amaro P, Aranibar L. “Pyoderma gangrenosum. Report of eleven cases”. Rev Méd Chile 2001; 129: 1044-50.

  8. Reichrath J, Bens G, Bonowitz A. “Treatment recomendations for pyoderma gangrenosum: An evidence based review of the literature based on more than 350 patients”. J Am Acad Dermatol 2005; 53: 273-283.

  9. Ghosn S, Malek J, Shbaklo Z y cols. “Takayasu disease presenting as malignant pyoderma gangrenosum in a child with relapsing polychondritis”. J Am Acad Dermatol 2008; 59: S84-S87.

  10. Brooklyn T, Dunnill G, Robert C. “Diagnosis and treatment of pyoderma gangrenosum”. BMJ 2006; 333: 181-184.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Dermatología Cosmética, Médica y Quirúrgica. 2010;8